Arvind Dasari, MD

The University of Texas MD Anderson Cancer Center

Dr. Dasari is a medical oncologist in the Dept of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center .
As a member of Southwest Oncology Group (SWOG) and NRG Oncology, he serves on their GI and Colorectal Cancers Committees.
His primary research focus is in phase I-III clinical trial development using novel therapeutics inclusive of blood and tissue correlatives for biomarker discovery and enhanced drug utilization in the treatment of gastrointestinal malignancies with a focus on colorectal and neuroendocrine cancers.
He currently leads several ongoing trials in colorectal cancer including those involving ctDNA

Presentation(s):

• Debate: Is Circulating Tumor DNA (ctDNA) Ready to Direct Adjuvant Therapy? Yes.

  Thursday, October 28, 2021
  1:10 PM – 1:18 PM CDT

• Debate Discussion

  Thursday, October 28, 2021
  1:26 PM – 1:30 PM CDT

• Q&A; Post-Session Audience Survey

  Thursday, October 28, 2021
  1:50 PM – 2:35 PM CDT

• Debate: ctDNA: Can it Help Guide Therapy in Advanced Gastrointestinal Cancers? Yes or No. - Yes

  Saturday, October 30, 2021
  11:20 AM – 11:28 AM CDT

• Debate Discussion

  Saturday, October 30, 2021
  11:36 AM – 11:40 AM CDT

• Q&A; Post-Session Audience Survey

  Saturday, October 30, 2021
  12:10 PM – 12:55 PM CDT